Linet al. [32] showed that thedownregulated or absent expression of MALAT1 is typical mostly of normaltissue, while MALAT1 overexpression is characteristic of breast, pancreatic,liver, lung, colorectal, and prostate cancers. Here, MALAT1 is linked to prostate carcinoma.